Literature DB >> 9028940

Cell-cycle-dependent regulation of erythropoietin receptor gene.

N Komatsu1, K Kirito, Y Kashii, Y Furukawa, J Kikuchi, N Suwabe, M Yamamoto, Y Miura.   

Abstract

To understand the regulatory mechanism of erythropoietin (EPO) receptor (EPOR) gene expression, the effect of EPO on the steady-state level of EPOR mRNA was examined using the human EPO-dependent cell line UT-7 as a model system. We found that the treatment of UT-7 cells with EPO resulted in a transient decrease of the EPOR mRNA level. This transient downregulation was also induced by stimulation with granulocyte-macrophage colony-stimulating factor (GM-CSF), another stimulator of UT-7 cell growth. These results raised the possibility that EPOR gene expression is in part related to cell growth. Moreover, it was found that EPO-induced downregulation of EPOR mRNA level was preceded by a transient downregulation of GATA-1 mRNA. To examine the relationship between the expression of EPOR, GATA-1, and GATA-2 mRNA levels and the cell cycle, logarithmically growing UT-7 cells were centrifugically fractionated according to the cell-cycle phase. Both EPOR and GATA-1 mRNA levels, but not the GATA-2 mRNA level, concomitantly decreased at the G0/G1 phase and increased at the S and G2/M phases. An electrophoretic mobility shift assay (EMSA) showed that in EPO-stimulated UT-7 cells, the dynamic changes in EPOR gene expression paralleled the GATA-1 DNA-binding activity to the oligonucleotide probe containing a GATA-binding site located at the promoter region of the EPOR gene. These findings suggest that the regulation of EPOR mRNA level is mainly associated with GATA-1 gene expression in UT-7 cells undergoing proliferation, and that these serial events are under the control of, or related to, the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028940

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Mice over-expressing human erythropoietin indicate that erythropoietin enhances expression of its receptor via up-regulated Gata1 and Tal1.

Authors:  Philipp Deindl; Martin Klar; David Drews; Malte Cremer; Elena Gammella; Max Gassmann; Christof Dame
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

2.  Identification of novel functional sequence variants in the gene for peptidase inhibitor 3.

Authors:  Mahboob A Chowdhury; Helena Kuivaniemi; Roberto Romero; Samuel Edwin; Tinnakorn Chaiworapongsa; Gerard Tromp
Journal:  BMC Med Genet       Date:  2006-05-23       Impact factor: 2.103

3.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27

4.  A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin.

Authors:  Gudjon R Oskarsson; Ragnar P Kristjansson; Amy L Lee; Gardar Sveinbjornsson; Magnus K Magnusson; Erna V Ivarsdottir; Stefania Benonisdottir; Asmundur Oddsson; Olafur B Davidsson; Jona Saemundsdottir; Gisli H Halldorsson; Joseph Arthur; Gudny A Arnadottir; Gisli Masson; Brynjar O Jensson; Hilma Holm; Isleifur Olafsson; Pall T Onundarson; Daniel F Gudbjartsson; Gudmundur L Norddahl; Unnur Thorsteinsdottir; Patrick Sulem; Kari Stefansson
Journal:  Commun Biol       Date:  2018-05-17

5.  The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus.

Authors:  Martha Catalina Rivera-Cervantes; José Jaime Jarero-Basulto; Justo Murguía-Castillo; Alejandra Guadalupe Marín-López; Yadira Gasca-Martínez; Sergio Cornelio-Martínez; Carlos Beas-Zárate
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.